CDSCO takes steps to prevent illegal manufacturing, sale and distribution of Oxytocin

CDSCO takes steps to prevent illegal manufacturing, sale and distribution of Oxytocin

CDSCO takes steps to prevent illegal manufacturing, sale and distribution of Oxytocin

by Lexplosion | May 28, 2018 | Healthcare, OPS, Pharmaceuticals, states

An Office Memorandum dated 21st May, 2018, has been issued by the Central Drugs Standard Control... Read More

CDSCO announces list of Notified Bodies under the Medical Devices Rules, 2017

CDSCO announces list of Notified Bodies under the Medical Devices Rules, 2017

by Lexplosion | May 9, 2018 | OPS, Pharmaceuticals, states

The Central Drugs Standard Control Organization (“CDSCO”), in a notice dated 4th May, 2018, has... Read More

CDSCO issues a list of spurious, adulterated, misbranded, or not of standard quality drugs and devices

CDSCO issues a list of spurious, adulterated, misbranded, or not of standard quality drugs and devices

by Lexplosion | Apr 26, 2018 | OPS, Pharmaceuticals, states

In the Safety Alert section of its official website, Central Drugs Standard Control... Read More

Central Drugs Standard Control Organization issues a list of FAQs pertaining to the Medical Device Rules 2017

by Lexplosion | Mar 23, 2018 | Healthcare, OPS, Pharmaceuticals, states

By way of a notification dated March 16, 2018, the Central Drugs Standard Control... Read More

CDSCO further modifies the NOC requirement for Export Consignments from India

by Lexplosion | Mar 23, 2018 | Healthcare, OPS, Pharmaceuticals, states

The Central Drugs Standard Control Organization (“CDSCO”) has issued notice no. DCGI/MIS/2015(199)... Read More

« Older Entries

Next Entries »